Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions

Daniel J. Weiss; Leigh Turner; Aaron D. Levine; Laertis Ikonomou

doi:10.1016/j.jcyt.2017.10.002

Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions

Daniel J. Weiss
, Leigh Turner
, Aaron D. Levine
, Laertis Ikonomou^*

^*Corresponding author for this work

University of Vermont
International Society for Cellular Therapy Presidential Task Force on the Use of Unproven Cellular Therapies
School of Public Health
Georgia Institute of Technology
Boston Medical Center

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Abstract

Businesses marketing unproven stem cell interventions proliferate within the U.S. and in the larger global marketplace. There have been global efforts by scientists, patient advocacy groups, bioethicists, and public policy experts to counteract the uncontrolled and premature commercialization of stem cell interventions. In this commentary, we posit that medical societies and associations of health care professionals have a particular responsibility to be an active partner in such efforts.

Original language	English
Pages (from-to)	165-168
Number of pages	4
Journal	Cytotherapy
Volume	20
Issue number	2
DOIs	https://doi.org/10.1016/j.jcyt.2017.10.002
State	Published - Feb 2018
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

health care professionals
medical societies
patients
unproven stem cell interventions
“stem cell” clinics

Access to Document

10.1016/j.jcyt.2017.10.002

Cite this

@article{cc722bf29c2c47bb9542fe54845f5657,

title = "Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions",

abstract = "Businesses marketing unproven stem cell interventions proliferate within the U.S. and in the larger global marketplace. There have been global efforts by scientists, patient advocacy groups, bioethicists, and public policy experts to counteract the uncontrolled and premature commercialization of stem cell interventions. In this commentary, we posit that medical societies and associations of health care professionals have a particular responsibility to be an active partner in such efforts.",

keywords = "health care professionals, medical societies, patients, unproven stem cell interventions, “stem cell” clinics",

author = "Weiss, \{Daniel J.\} and Leigh Turner and Levine, \{Aaron D.\} and Laertis Ikonomou",

note = "Publisher Copyright: {\textcopyright} 2017 International Society for Cellular Therapy",

year = "2018",

month = feb,

doi = "10.1016/j.jcyt.2017.10.002",

language = "Ingl{\'e}s",

volume = "20",

pages = "165--168",

journal = "Cytotherapy",

issn = "1465-3249",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions

AU - Weiss, Daniel J.

AU - Turner, Leigh

AU - Levine, Aaron D.

AU - Ikonomou, Laertis

PY - 2018/2

Y1 - 2018/2

N2 - Businesses marketing unproven stem cell interventions proliferate within the U.S. and in the larger global marketplace. There have been global efforts by scientists, patient advocacy groups, bioethicists, and public policy experts to counteract the uncontrolled and premature commercialization of stem cell interventions. In this commentary, we posit that medical societies and associations of health care professionals have a particular responsibility to be an active partner in such efforts.

AB - Businesses marketing unproven stem cell interventions proliferate within the U.S. and in the larger global marketplace. There have been global efforts by scientists, patient advocacy groups, bioethicists, and public policy experts to counteract the uncontrolled and premature commercialization of stem cell interventions. In this commentary, we posit that medical societies and associations of health care professionals have a particular responsibility to be an active partner in such efforts.

KW - health care professionals

KW - medical societies

KW - patients

KW - unproven stem cell interventions

KW - “stem cell” clinics

UR - https://www.scopus.com/pages/publications/85035124507

U2 - 10.1016/j.jcyt.2017.10.002

DO - 10.1016/j.jcyt.2017.10.002

M3 - Artículo

C2 - 29239793

AN - SCOPUS:85035124507

SN - 1465-3249

VL - 20

SP - 165

EP - 168

JO - Cytotherapy

JF - Cytotherapy

IS - 2

ER -

Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this